-
DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects
Dombrowsky, G., van der Laan, L., Silva, A., Breckpot, J., Audain, E., Wilsdon, A., Levy, M. A., Vos, N., Mannens, M., Wang, J., Jain, A., Lesurf, R., Winlaw, D., Bezzina, C. R., Thomas, M. A., Caliebe, A., Klaassen, S., Berger, F., Dittrich, S. & Stiller, B. & 15 others, , 1 Dec 2026, In: Genome Medicine. 18, 1, 2.Research output: Contribution to journal › Article › Academic › peer-review
-
Fatal persistent pulmonary hypertension as part of 3q11.1-q21.3 deletion syndrome?
Lo A Njoe, S. M., van der Laan, L., Postma, A. V., van Doorn, A., Ecury-Goossen, G. M. & van Haelst, M. M., 5 Dec 2025, In: Medical Reports.Research output: Contribution to journal › Article › Academic › peer-review
-
Discovery of a DNA methylation episignature as a molecular biomarker for fetal alcohol syndrome
van der Laan, L., Relator, R., Valenzuela, I., Mul, A. N., Alders, M., Levy, M. A., Kerkhof, J., Rzasa, J., Cueto-González, A. M., Lasa-Aranzasti, A., Cea-Arestin, C., Mannens, M. M. A. M., van Haelst, M. M., Tizzano, E. F., Sadikovic, B. & Henneman, P., 1 Dec 2025, In: Genetics in Medicine. 27, 12, 101586.Research output: Contribution to journal › Article › Academic › peer-review
- All publications